Skip to content

Effect of Jyotishmati capsule in the management of Chittodvega Generalized Anxiety Disorder

Evaluation of comparative efficacy of Jyotishmati Capsule versus Sertraline Capsule in the management of Chittodvega (Generalized Anxiety Disorder) – RCT - GAD

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057687
Enrollment
70
Registered
2023-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder

Interventions

None listed

Sponsors

Reeya Gamne
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing to take part in research study and ready to give written informed consent. 2. Patients will be selected according to DSM-V, ICD-10 criteria for anxiety disorders. 3. A score of less than 24on HAM-A scale. 4. Age group of 20 to 50 years of either sex. 5. Free of psychiatric conditions other than anxiety.

Exclusion criteria

Exclusion criteria: 1. Current primary diagnosis of a comorbid disorder deemed to require treatment prior to GAD, such as major depressive disorder, panic disorder, social phobia, obsessive compulsive disorder, post-traumatic stress disorder, or drug dependency. 2. Currently undertaking CBT with a psychologist condition. 3. GAD (Chittodvega) due to drug abuse, a medication and due to general medical state like Hyperthyroidism 4. Alcoholic, and Self-harm or suicide risk 5. Diagnosed with psychosis, schizophrenia, or bipolar illness currently or in the past 6. Treatment with sertraline for two or more weeks within the previous three months 7. Pregnant and lactating mothers.

Design outcomes

Primary

MeasureTime frame
Reduction in Hamilton A scoreTimepoint: 8 weeks

Secondary

MeasureTime frame
Serum Cortisol LevelsTimepoint: 60 days (8weeks)

Countries

India

Contacts

Public ContactReeya Gamne

Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Hirapur Wardha

sadhanamisar@gmail.com9763732083

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026